000147400 001__ 147400
000147400 005__ 20240229121831.0
000147400 0247_ $$2doi$$a10.1186/s12872-019-1187-z
000147400 0247_ $$2pmid$$apmid:31664920
000147400 0247_ $$2altmetric$$aaltmetric:69563062
000147400 037__ $$aDKFZ-2019-02517
000147400 041__ $$aeng
000147400 082__ $$a610
000147400 1001_ $$00000-0003-1327-0424$$aSchmidt, Amand F$$b0
000147400 245__ $$aPhenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9.
000147400 260__ $$aLondon$$bBioMed Central$$c2019
000147400 3367_ $$2DRIVER$$aarticle
000147400 3367_ $$2DataCite$$aOutput Types/Journal article
000147400 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1582282111_27317
000147400 3367_ $$2BibTeX$$aARTICLE
000147400 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000147400 3367_ $$00$$2EndNote$$aJournal Article
000147400 520__ $$aWe characterised the phenotypic consequence of genetic variation at the PCSK9 locus and compared findings with recent trials of pharmacological inhibitors of PCSK9.Published and individual participant level data (300,000+ participants) were combined to construct a weighted PCSK9 gene-centric score (GS). Seventeen randomized placebo controlled PCSK9 inhibitor trials were included, providing data on 79,578 participants. Results were scaled to a one mmol/L lower LDL-C concentration.The PCSK9 GS (comprising 4 SNPs) associations with plasma lipid and apolipoprotein levels were consistent in direction with treatment effects. The GS odds ratio (OR) for myocardial infarction (MI) was 0.53 (95% CI 0.42; 0.68), compared to a PCSK9 inhibitor effect of 0.90 (95% CI 0.86; 0.93). For ischemic stroke ORs were 0.84 (95% CI 0.57; 1.22) for the GS, compared to 0.85 (95% CI 0.78; 0.93) in the drug trials. ORs with type 2 diabetes mellitus (T2DM) were 1.29 (95% CI 1.11; 1.50) for the GS, as compared to 1.00 (95% CI 0.96; 1.04) for incident T2DM in PCSK9 inhibitor trials. No genetic associations were observed for cancer, heart failure, atrial fibrillation, chronic obstructive pulmonary disease, or Alzheimer's disease - outcomes for which large-scale trial data were unavailable.Genetic variation at the PCSK9 locus recapitulates the effects of therapeutic inhibition of PCSK9 on major blood lipid fractions and MI. While indicating an increased risk of T2DM, no other possible safety concerns were shown; although precision was moderate.
000147400 536__ $$0G:(DE-HGF)POF3-323$$a323 - Metabolic Dysfunction as Risk Factor (POF3-323)$$cPOF3-323$$fPOF III$$x0
000147400 588__ $$aDataset connected to CrossRef, PubMed,
000147400 7001_ $$aHolmes, Michael V$$b1
000147400 7001_ $$aPreiss, David$$b2
000147400 7001_ $$aSwerdlow, Daniel I$$b3
000147400 7001_ $$aDenaxas, Spiros$$b4
000147400 7001_ $$aFatemifar, Ghazaleh$$b5
000147400 7001_ $$aFaraway, Rupert$$b6
000147400 7001_ $$aFinan, Chris$$b7
000147400 7001_ $$aValentine, Dennis$$b8
000147400 7001_ $$aFairhurst-Hunter, Zammy$$b9
000147400 7001_ $$aHartwig, Fernando Pires$$b10
000147400 7001_ $$aHorta, Bernardo Lessa$$b11
000147400 7001_ $$aHypponen, Elina$$b12
000147400 7001_ $$aPower, Christine$$b13
000147400 7001_ $$aMoldovan, Max$$b14
000147400 7001_ $$avan Iperen, Erik$$b15
000147400 7001_ $$aHovingh, Kees$$b16
000147400 7001_ $$aDemuth, Ilja$$b17
000147400 7001_ $$aNorman, Kristina$$b18
000147400 7001_ $$aSteinhagen-Thiessen, Elisabeth$$b19
000147400 7001_ $$aDemuth, Juri$$b20
000147400 7001_ $$aBertram, Lars$$b21
000147400 7001_ $$aLill, Christina M$$b22
000147400 7001_ $$aCoassin, Stefan$$b23
000147400 7001_ $$aWilleit, Johann$$b24
000147400 7001_ $$aKiechl, Stefan$$b25
000147400 7001_ $$aWilleit, Karin$$b26
000147400 7001_ $$aMason, Dan$$b27
000147400 7001_ $$aWright, John$$b28
000147400 7001_ $$aMorris, Richard$$b29
000147400 7001_ $$aWanamethee, Goya$$b30
000147400 7001_ $$aWhincup, Peter$$b31
000147400 7001_ $$aBen-Shlomo, Yoav$$b32
000147400 7001_ $$aMcLachlan, Stela$$b33
000147400 7001_ $$aPrice, Jackie F$$b34
000147400 7001_ $$aKivimaki, Mika$$b35
000147400 7001_ $$aWelch, Catherine$$b36
000147400 7001_ $$aSanchez-Galvez, Adelaida$$b37
000147400 7001_ $$aMarques-Vidal, Pedro$$b38
000147400 7001_ $$aNicolaides, Andrew$$b39
000147400 7001_ $$aPanayiotou, Andrie G$$b40
000147400 7001_ $$aOnland-Moret, N Charlotte$$b41
000147400 7001_ $$avan der Schouw, Yvonne T$$b42
000147400 7001_ $$aMatullo, Giuseppe$$b43
000147400 7001_ $$aFiorito, Giovanni$$b44
000147400 7001_ $$aGuarrera, Simonetta$$b45
000147400 7001_ $$aSacerdote, Carlotta$$b46
000147400 7001_ $$aWareham, Nicholas J$$b47
000147400 7001_ $$aLangenberg, Claudia$$b48
000147400 7001_ $$aScott, Robert A$$b49
000147400 7001_ $$aLuan, Jian'an$$b50
000147400 7001_ $$aBobak, Martin$$b51
000147400 7001_ $$aMalyutina, Sofia$$b52
000147400 7001_ $$aPająk, Andrzej$$b53
000147400 7001_ $$aKubinova, Ruzena$$b54
000147400 7001_ $$aTamosiunas, Abdonas$$b55
000147400 7001_ $$aPikhart, Hynek$$b56
000147400 7001_ $$aGrarup, Niels$$b57
000147400 7001_ $$aPedersen, Oluf$$b58
000147400 7001_ $$aHansen, Torben$$b59
000147400 7001_ $$aLinneberg, Allan$$b60
000147400 7001_ $$aJess, Tine$$b61
000147400 7001_ $$aCooper, Jackie$$b62
000147400 7001_ $$aHumphries, Steve E$$b63
000147400 7001_ $$aBrilliant, Murray$$b64
000147400 7001_ $$aKitchner, Terrie$$b65
000147400 7001_ $$aHakonarson, Hakon$$b66
000147400 7001_ $$aCarrell, David S$$b67
000147400 7001_ $$aMcCarty, Catherine A$$b68
000147400 7001_ $$aLester, Kirchner H$$b69
000147400 7001_ $$aLarson, Eric B$$b70
000147400 7001_ $$aCrosslin, David R$$b71
000147400 7001_ $$ade Andrade, Mariza$$b72
000147400 7001_ $$aRoden, Dan M$$b73
000147400 7001_ $$aDenny, Joshua C$$b74
000147400 7001_ $$aCarty, Cara$$b75
000147400 7001_ $$aHancock, Stephen$$b76
000147400 7001_ $$aAttia, John$$b77
000147400 7001_ $$aHolliday, Elizabeth$$b78
000147400 7001_ $$aScott, Rodney$$b79
000147400 7001_ $$aSchofield, Peter$$b80
000147400 7001_ $$aO'Donnell, Martin$$b81
000147400 7001_ $$aYusuf, Salim$$b82
000147400 7001_ $$aChong, Michael$$b83
000147400 7001_ $$aPare, Guillaume$$b84
000147400 7001_ $$avan der Harst, Pim$$b85
000147400 7001_ $$aSaid, M Abdullah$$b86
000147400 7001_ $$aEppinga, Ruben N$$b87
000147400 7001_ $$aVerweij, Niek$$b88
000147400 7001_ $$aSnieder, Harold$$b89
000147400 7001_ $$aauthors, Lifelines Cohort$$b90$$eCollaboration Author
000147400 7001_ $$aChristen, Tim$$b91
000147400 7001_ $$aMook-Kanamori, D. O.$$b92
000147400 7001_ $$aConsortium, ICBP$$b93$$eCollaboration Author
000147400 7001_ $$aGustafsson, Stefan$$b94
000147400 7001_ $$aLind, Lars$$b95
000147400 7001_ $$aIngelsson, Erik$$b96
000147400 7001_ $$aPazoki, Raha$$b97
000147400 7001_ $$aFranco, Oscar$$b98
000147400 7001_ $$aHofman, Albert$$b99
000147400 7001_ $$aUitterlinden, Andre$$b100
000147400 7001_ $$aDehghan, Abbas$$b101
000147400 7001_ $$aTeumer, Alexander$$b102
000147400 7001_ $$aBaumeister, Sebastian$$b103
000147400 7001_ $$aDörr, Marcus$$b104
000147400 7001_ $$aLerch, Markus M$$b105
000147400 7001_ $$aVölker, Uwe$$b106
000147400 7001_ $$aVölzke, Henry$$b107
000147400 7001_ $$aWard, Joey$$b108
000147400 7001_ $$aPell, Jill P$$b109
000147400 7001_ $$aMeade, Tom$$b110
000147400 7001_ $$aChristophersen, Ingrid E$$b111
000147400 7001_ $$aMaitland-van der Zee, Anke H$$b112
000147400 7001_ $$aBaranova, Ekaterina V$$b113
000147400 7001_ $$aYoung, Robin$$b114
000147400 7001_ $$aFord, Ian$$b115
000147400 7001_ $$aCampbell, Archie$$b116
000147400 7001_ $$aPadmanabhan, Sandosh$$b117
000147400 7001_ $$aBots, Michiel L$$b118
000147400 7001_ $$aGrobbee, Diederick E$$b119
000147400 7001_ $$aFroguel, Philippe$$b120
000147400 7001_ $$aThuillier, Dorothée$$b121
000147400 7001_ $$aRoussel, Ronan$$b122
000147400 7001_ $$aBonnefond, Amélie$$b123
000147400 7001_ $$aCariou, Bertrand$$b124
000147400 7001_ $$aSmart, Melissa$$b125
000147400 7001_ $$aBao, Yanchun$$b126
000147400 7001_ $$aKumari, Meena$$b127
000147400 7001_ $$aMahajan, Anubha$$b128
000147400 7001_ $$aHopewell, Jemma C$$b129
000147400 7001_ $$aSeshadri, Sudha$$b130
000147400 7001_ $$aISGC, METASTROKE Consortium of the$$b131$$eCollaboration Author
000147400 7001_ $$aDale, Caroline$$b132
000147400 7001_ $$aCosta, Rui Providencia E$$b133
000147400 7001_ $$aRidker, Paul M$$b134
000147400 7001_ $$aChasman, Daniel I$$b135
000147400 7001_ $$aReiner, Alex P$$b136
000147400 7001_ $$aRitchie, Marylyn D$$b137
000147400 7001_ $$aLange, Leslie A$$b138
000147400 7001_ $$aCornish, Alex J$$b139
000147400 7001_ $$aDobbins, Sara E$$b140
000147400 7001_ $$0P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aHemminki, Kari$$b141$$udkfz
000147400 7001_ $$aKinnersley, Ben$$b142
000147400 7001_ $$aSanson, Marc$$b143
000147400 7001_ $$aLabreche, Karim$$b144
000147400 7001_ $$aSimon, Matthias$$b145
000147400 7001_ $$aBondy, Melissa$$b146
000147400 7001_ $$aLaw, Philip$$b147
000147400 7001_ $$aSpeedy, Helen$$b148
000147400 7001_ $$aAllan, James$$b149
000147400 7001_ $$aLi, Ni$$b150
000147400 7001_ $$aWent, Molly$$b151
000147400 7001_ $$aWeinhold, Niels$$b152
000147400 7001_ $$aMorgan, Gareth$$b153
000147400 7001_ $$aSonneveld, Pieter$$b154
000147400 7001_ $$aNilsson, Björn$$b155
000147400 7001_ $$aGoldschmidt, Hartmut$$b156
000147400 7001_ $$aSud, Amit$$b157
000147400 7001_ $$aEngert, Andreas$$b158
000147400 7001_ $$aHansson, Markus$$b159
000147400 7001_ $$aHemingway, Harry$$b160
000147400 7001_ $$aAsselbergs, Folkert W$$b161
000147400 7001_ $$aPatel, Riyaz S$$b162
000147400 7001_ $$aKeating, Brendan J$$b163
000147400 7001_ $$aSattar, Naveed$$b164
000147400 7001_ $$aHoulston, Richard$$b165
000147400 7001_ $$aCasas, Juan P$$b166
000147400 7001_ $$aHingorani, Aroon D$$b167
000147400 773__ $$0PERI:(DE-600)2059859-2$$a10.1186/s12872-019-1187-z$$gVol. 19, no. 1, p. 240$$n1$$p240$$tBMC cardiovascular disorders$$v19$$x1471-2261$$y2019
000147400 909CO $$ooai:inrepo02.dkfz.de:147400$$pVDB
000147400 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)19b0ec1cea271419d9fa8680e6ed6865$$aDeutsches Krebsforschungszentrum$$b141$$kDKFZ
000147400 9131_ $$0G:(DE-HGF)POF3-323$$1G:(DE-HGF)POF3-320$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lHerz-Kreislauf-Stoffwechselerkrankungen$$vMetabolic Dysfunction as Risk Factor$$x0
000147400 9141_ $$y2019
000147400 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBMC CARDIOVASC DISOR : 2017
000147400 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000147400 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000147400 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000147400 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000147400 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000147400 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000147400 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Open peer review
000147400 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000147400 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000147400 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000147400 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000147400 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000147400 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000147400 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000147400 980__ $$ajournal
000147400 980__ $$aVDB
000147400 980__ $$aI:(DE-He78)C020-20160331
000147400 980__ $$aUNRESTRICTED